{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T08:31:14Z","timestamp":1740126674863,"version":"3.37.3"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,2,13]],"date-time":"2018-02-13T00:00:00Z","timestamp":1518480000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Hungarian National Research and Development Fund","award":["NKFP_07_2-SPE-SAFE, Jedlik \u00c1nyos 2. subprogram KMR_12-1-2012-0032","NKFP_07_2-SPE-SAFE, Jedlik \u00c1nyos 2. subprogram KMR_12-1-2012-0032"],"award-info":[{"award-number":["NKFP_07_2-SPE-SAFE, Jedlik \u00c1nyos 2. subprogram KMR_12-1-2012-0032","NKFP_07_2-SPE-SAFE, Jedlik \u00c1nyos 2. subprogram KMR_12-1-2012-0032"]}]},{"name":"Hungarian National Research Foundation","award":["OTKA PD105019"],"award-info":[{"award-number":["OTKA PD105019"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pathol. Oncol. Res."],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s12253-018-0384-x","type":"journal-article","created":{"date-parts":[[2018,2,13]],"date-time":"2018-02-13T22:30:50Z","timestamp":1518561050000},"page":"477-486","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Dual-Stained Cervical Cytology and Histology with Claudin-1 and Ki67"],"prefix":"10.1007","volume":"25","author":[{"given":"T\u00edmea","family":"Szekercz\u00e9s","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1d\u00e1m","family":"Galamb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrienn","family":"Kocsis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e1rta","family":"Benczik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tibor","family":"Tak\u00e1cs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Attila","family":"Martonos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bal\u00e1zs","family":"J\u00e1ray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e1s","family":"Kiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Csaba","family":"Jeney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikl\u00f3s","family":"Ny\u00edri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6429-8059","authenticated-orcid":false,"given":"Zsuzsa","family":"Schaff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00e1bor","family":"Sobel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,2,13]]},"reference":[{"key":"384_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000448385","volume":"39","author":"P Hillemans","year":"2016","unstructured":"Hillemans P, Soergel P, Hertel H, Jentschke M (2016) Epidemiology and early detection of cervical cancer. Oncol Res Treat 39:1\u20136","journal-title":"Oncol Res Treat"},{"key":"384_CR2","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1097\/AOG.0000000000001136","volume":"127","author":"GF Sawaya","year":"2016","unstructured":"Sawaya GF, Smith-McCune K (2016) Cervical cancer screening. Obstet Gynecol 127:459\u2013467","journal-title":"Obstet Gynecol"},{"key":"384_CR3","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.ajog.2015.10.147","volume":"214","author":"BF Lees","year":"2016","unstructured":"Lees BF, Erickson BK, Huh WK (2016) Cervical cancer screening: evidence behind the guidelines. Am J Obstet Gynecol 214:438\u2013443","journal-title":"Am J Obstet Gynecol"},{"key":"384_CR4","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1093\/ajcp\/aqw040","volume":"145","author":"R Ocque","year":"2016","unstructured":"Ocque R, Austin RM (2016) Follow-up of women with negative pap test results and abnormal clinical signs or symptoms. Am J Clin Pathol 145:560\u2013567","journal-title":"Am J Clin Pathol"},{"key":"384_CR5","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1093\/jnci\/djt235","volume":"105","author":"H Ikenberg","year":"2013","unstructured":"Ikenberg H, Bergeron C, Schmidt D, Griesser H, Alameda F, Angeloni C, Bogers J, Dachez R, Denton K, Hariri J, Keller T, von Knebel Doeberitz M, Neumann HH, Puig-Tintore LM, Sideri M, Rehm S, Ridder R, PALMS Study Group (2013) Screening for cervical cancer precursors with p16\/Ki-67 dual-stained cytology: results of the PALMS study. J Natl Cancer Inst 105:1550\u20131557","journal-title":"J Natl Cancer Inst"},{"key":"384_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jnci\/djv257","volume":"107","author":"N Wentzensen","year":"2015","unstructured":"Wentzensen N, Fetterman B, Castle PE, Schiffman M, Wood SN, Stiemerling E, Tokugawa D, Bodelon C, Roitras N, Lorey T, Kinney W (2015) p16\/Ki-67 dual stain cytology for detection of cervical precancer in HPV-positive women. J Natl Cancer Inst 107:1\u20138","journal-title":"J Natl Cancer Inst"},{"key":"384_CR7","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1002\/ijc.21955","volume":"119","author":"J Cuzick","year":"2006","unstructured":"Cuzick J, Clavel C, Petry KU, Meijer CJ, Hoyer H, Ratnam S, Szarewski A, Birembaut P, Kulasingam S, Sasieni P, Iftner T (2006) Overview of the European and north American studies on HPV testing in primary cervical cancer screening. Int J Cancer 119:1095\u20131101","journal-title":"Int J Cancer"},{"key":"384_CR8","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1086\/516784","volume":"195","author":"M Plummer","year":"2007","unstructured":"Plummer M, Schiffman M, Castle PE, Maucort-Boulch D, Wheeler CM, ALTS Group (2007) A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion. J Infect Dis 195:1582\u20131589","journal-title":"J Infect Dis"},{"key":"384_CR9","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s12253-015-9990-z","volume":"22","author":"M Benczik","year":"2016","unstructured":"Benczik M, Galamb \u00c1, Koiss R, Kov\u00e1cs A, J\u00e1ray B, Sz\u00e9kely T, Szekercz\u00e9s T, Schaff Z, Sobel G, Jeney C (2016) Claudin-1 as a biomarker of cervical cytology and histology. Pathol Oncol Res 22:179\u2013188","journal-title":"Pathol Oncol Res"},{"key":"384_CR10","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/cncy.21542","volume":"123","author":"C Bergeron","year":"2015","unstructured":"Bergeron C, Ikenberg H, Sideri M, Denton K, Bogers J, Schmidt D, Alameda F, Keller T, Rehm S, Ridder R, PALMS Study Group (2015) Prospective evaluation of p16\/Ki-67 dual-stained cytology for managing women with abnormal Papanicolaou cytology: PALMS study results. Cancer Cytopathol 123:373\u2013381","journal-title":"Cancer Cytopathol"},{"key":"384_CR11","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1002\/ijc.30534","volume":"140","author":"A Kocsis","year":"2017","unstructured":"Kocsis A, Tak\u00e1cs T, Jeney C, Schaff Z, Koiss R, J\u00e1ray B, Sobel G, Pap K, Sz\u00e9kely I, Ferenci T, Lai HC, Ny\u00edri M, Benczik M (2017) Performance of a new HPV and biomarker assay in management of hrHPV positive women: Subanalysis of the ongoing multicenter TRACE Clinical Trial (n>6,000) to evaluate POU4F3 as a potential biomarker of cervical precancer and cancer. Int J Cancer 140:1119\u20131133","journal-title":"Int J Cancer"},{"key":"384_CR12","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.humpath.2004.12.001","volume":"36","author":"G Sobel","year":"2005","unstructured":"Sobel G, P\u00e1ska C, Szab\u00f3 I, Kiss A, K\u00e1d\u00e1r A, Schaff Z (2005) Increased expression of claudins in cervical squamous intraepithelial neoplasia and invasive carcinoma. Hum Pathol 36:162\u2013169","journal-title":"Hum Pathol"},{"key":"384_CR13","first-page":"1607","volume":"24","author":"I Szabo","year":"2009","unstructured":"Szabo I, Kiss A, Schaff Z, Sobel G (2009) Claudins as diagnostic and prognostic markers in gynecological cancer. Histol Histopathol 24:1607\u20131615","journal-title":"Histol Histopathol"},{"key":"384_CR14","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ygyno.2004.11.058","volume":"97","author":"JW Lee","year":"2005","unstructured":"Lee JW, Lee SJ, Seo J, Song SY, Ahn G, Park CS, Lee JH, Kim BG, Bae DS (2005) Increased expressions of claudin-1 and claudin-7 during the progression of cervical neoplasia. Gynecol Oncol 97:53\u201359","journal-title":"Gynecol Oncol"},{"key":"384_CR15","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/gb-2009-10-8-235","volume":"10","author":"M Lal-Nag","year":"2009","unstructured":"Lal-Nag M, Morin PJ (2009) The claudins. Genome Biol 10:235","journal-title":"Genome Biol"},{"key":"384_CR16","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/cncy.21521","volume":"123","author":"R Nayar","year":"2015","unstructured":"Nayar R, Wilbur DC (2015) The pap test and Bethesda 2014. Cancer Cytopathol 123:271\u2013281","journal-title":"Cancer Cytopathol"},{"key":"384_CR17","unstructured":"Solomon D (2015) Foreword. In: Nayar F, Wilbur DC (ed) The Bethesda system for reporting cervical cytology. Definitions, criteria, and explanatory notes, 3rd ed. Springer International Publishing Switzerland, Cham, pp v-vii"},{"key":"384_CR18","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1155\/2007\/678793","volume":"23","author":"N Wentzensen","year":"2007","unstructured":"Wentzensen N, von Knebel Doeberitz M (2007) Biomarkers in cervical cancer screening. Dis Markers 23:315\u2013330","journal-title":"Dis Markers"},{"key":"384_CR19","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1097\/PGP.0000000000000345","volume":"36","author":"S Lee","year":"2017","unstructured":"Lee S, Rose MS, Sahasrabuddhe VV, Zhao R, Duggan MA (2017) Tissue-based immunohistochemical biomarker accuracy in the diagnosis of malignant glandular lesions of the uterine cervix: a systematic review of the literature and meta-analysis. Int J Gynecol Pathol 36:310\u2013322","journal-title":"Int J Gynecol Pathol"},{"key":"384_CR20","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1002\/ijc.30449","volume":"140","author":"NJ Polman","year":"2017","unstructured":"Polman NJ, Uijterwaal MH, Witte BI, Berkhof J, van Kemenade FJ, Spruijt JW, van Baal WM, Graziosi PG, van Dijken DK, Verheijen RH, Helmerhorst TJ, Steenbergen RD, Heideman DA, Ridder R, Snijders PJ, Meijer CJ (2017) Good performance of p16\/ki-67 dual-stained cytology for surveillance of women treated for high-grade CIN. Int J Cancer 140:423\u2013430","journal-title":"Int J Cancer"},{"key":"384_CR21","doi-asserted-by":"crossref","first-page":"64810","DOI":"10.18632\/oncotarget.11705","volume":"7","author":"LL Yu","year":"2016","unstructured":"Yu LL, Guo HQ, Lei XQ, Qin Y, Wu ZN, Kang LN, Zhang X, Qiao YL, Chen W (2016) p16\/Ki-67 co-expression associates high risk human papillomavirus persistence and cervical histopathology: a 3-year cohort study in China. Oncotarget 7:64810\u201364819","journal-title":"Oncotarget"},{"key":"384_CR22","doi-asserted-by":"publisher","first-page":"e0134445","DOI":"10.1371\/journal.pone.0134445","volume":"10","author":"JC Possati-Resende","year":"2015","unstructured":"Possati-Resende JC, Fregnani JHTG, Kerr LM, Mauad EC, Longatto-Filho A, Scapulatempo-Neto C (2015) The accuracy of p16\/Ki67 and HPV test in the detection of CIN2\/3 in women diagnosed with ASC-US or LSIL. PLoS One 10:e0134445","journal-title":"PLoS One"},{"key":"384_CR23","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1083\/jcb.141.7.1539","volume":"141","author":"M Furuse","year":"1998","unstructured":"Furuse M, Fujita K, Hiiragi T, Fujimoto K, Tsukita S (1998) Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin. J Cell Biol 141:1539\u20131550","journal-title":"J Cell Biol"},{"key":"384_CR24","doi-asserted-by":"publisher","first-page":"9603","DOI":"10.1158\/0008-5472.CAN-05-2782","volume":"65","author":"PJ Morin","year":"2005","unstructured":"Morin PJ (2005) Claudin proteins in human cancer: promising new targets for diagnosis and therapy. Cancer Res 65:9603\u20139606","journal-title":"Cancer Res"},{"key":"384_CR25","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1111\/j.1365-2559.2005.02127.x","volume":"46","author":"Y Soini","year":"2005","unstructured":"Soini Y (2005) Expression of claudins 1, 2, 3, 4, 5 and 7 in various types of tumours. Histopathology 46:551\u2013560","journal-title":"Histopathology"},{"key":"384_CR26","first-page":"2851","volume":"34","author":"C Cunniffe","year":"2014","unstructured":"Cunniffe C, Brankin B, Lambkin H, Ryan F (2014) The role of claudin-1 and claudin-7 in cervical tumorigenesis. Anticancer Res 34:2851\u20132857","journal-title":"Anticancer Res"},{"key":"384_CR27","first-page":"921","volume":"31","author":"T Akimoto","year":"2016","unstructured":"Akimoto T, Takasawa A, Murata M, Kojima Y, Takasawa K, Nojima M, Aoyama T, Hiratsuka Y, Ono Y, Tanaka S, Osanai M, Hasegawa T, Saito T, Sawada N (2016) Analysis of the expression and localization of tight junction transmembrane proteins, claudin-1, \u22124, \u22127, occludin and JAM-A, in human cervical adenocarcinoma. Histol Histopathol 31:921\u2013931","journal-title":"Histol Histopathol"},{"key":"384_CR28","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s00428-005-0045-9","volume":"447","author":"H Gy\u0151rffy","year":"2005","unstructured":"Gy\u0151rffy H, Holczbauer \u00c1, Nagy P, Szab\u00f3 Z, Kupcsulik P, P\u00e1ska C, Papp J, Schaff Z, Kiss A (2005) Claudin expression in Barrett\u2019s esophagus and adenocarcinoma. Virchows Arch 447:961\u2013968","journal-title":"Virchows Arch"},{"key":"384_CR29","doi-asserted-by":"publisher","first-page":"R296","DOI":"10.1186\/bcr983","volume":"7","author":"AM T\u0151k\u00e9s","year":"2005","unstructured":"T\u0151k\u00e9s AM, Kulka J, Paku S, Szik \u00c1, P\u00e1ska C, Nov\u00e1k PK, Szil\u00e1k L, Kiss A, B\u00f6gi K, Schaff Z (2005) Claudin-1, \u22123 and \u22124 proteins and mRNA expression in benign and malignant breast lesions: a research study. Breast Cancer Res 7:R296\u2013R305","journal-title":"Breast Cancer Res"},{"key":"384_CR30","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/modpathol.3800549","volume":"19","author":"C L\u00f3di","year":"2006","unstructured":"L\u00f3di C, Szab\u00f3 E, Holczbauer \u00c1, Batmunkh E, Sz\u00edj\u00e1rt\u00f3 A, Kupcsulik P, Kovalszky I, Paku S, Illy\u00e9s G, Kiss A, Schaff Z (2006) Claudin-4 differentiates biliary tract cancers from hepatocellular carcinomas. Mod Pathol 19:460\u2013469","journal-title":"Mod Pathol"},{"key":"384_CR31","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1111\/j.1464-410X.2009.08808.x","volume":"105","author":"AM Sz\u00e1sz","year":"2010","unstructured":"Sz\u00e1sz AM, Ny\u00edr\u00e1dy P, Majoros A, Szendr\u0151i A, Sz\u0171cs M, Sz\u00e9kely E, T\u0151k\u00e9s AM, Romics I, Kulka J (2010) Beta-catenin expression and claudin expression pattern as prognostic factors of prostatic cancer progression. BJU Int 105:716\u2013722","journal-title":"BJU Int"},{"key":"384_CR32","doi-asserted-by":"publisher","first-page":"10412","DOI":"10.3390\/ijms140510412","volume":"14","author":"DP English","year":"2013","unstructured":"English DP, Santin AD (2013) Claudins overexpression in ovarian cancer: potential targets for Clostridium Perfringens enterotoxin (CPE) based diagnosis and therapy. Int J Mol Sci 14:10412\u201310437","journal-title":"Int J Mol Sci"},{"key":"384_CR33","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.arcmed.2005.04.016","volume":"36","author":"G V\u00e1zquez-Ort\u00edz","year":"2005","unstructured":"V\u00e1zquez-Ort\u00edz G, Ciudad CJ, Pina P, Vazquez K, Hidalgo A, Latorre B, Garcia JA, Salamanca F, Peralta-Rodriguez R, Rangel A, Salcedo M (2005) Gene identification by cDNA arrays in HPV-positive cervical cancer. Arch Med Res 36:448\u2013458","journal-title":"Arch Med Res"}],"container-title":["Pathology & Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12253-018-0384-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-018-0384-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-018-0384-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T03:51:26Z","timestamp":1603857086000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12253-018-0384-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,13]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["384"],"URL":"https:\/\/doi.org\/10.1007\/s12253-018-0384-x","relation":{},"ISSN":["1219-4956","1532-2807"],"issn-type":[{"type":"print","value":"1219-4956"},{"type":"electronic","value":"1532-2807"}],"subject":[],"published":{"date-parts":[[2018,2,13]]},"assertion":[{"value":"18 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest with respect to the research, authorship, and\/or publication of this article.AKo is an employee of Cellcall and NEUMANN. MB receives consultancy fees from Cellcall and NEUMANN, she is an employee of SYNLAB GenoID Laboratory, which participated in the TRACE clinical study (all related expenses were charged to Cellcall and NEUMANN). TT is a part time employee of Cellcall, he receives consultancy fees from NEUMANN, he is minority owner of NEUMANN, the inventor of the HPV detection technology described in the manuscript covering which Cellcall submitted a patent application (license now owned by NEUMANN Diagnostics Ltd.); he is a part time employee of SYNLAB GenoID Laboratory. CsJ was a former employee of Cellcall. MNy is an employee of Cellcall and NEUMANN.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}